1. 171: ADSCaN: A Randomised Phase II study of Accelerated, Dose escalated, Sequential Chemo-radiotherapy in Non-Small Cell Lung Cancer (NSCLC). (January 2017) Authors: Lawless, C.A.; Landau, D.B.; Faivre-Finn, C.; Boyd, K.; Lester, J.F.; Fenwick, J.; Maguire, J.; McCartney, E.; Paul, J.; Parsons, E.; Peek, A.; Haswell, T.; Hatton, M.Q. Journal: Lung cancer Issue: Volume 103(2017)Supplement 1 Page Start: S80 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 29: The NHS Wales–Novartis joint working project on lung cancer. (January 2017) Authors: Lester, J.F.; Rees, T.; Parry, D.; Davies, H.; Rowe, K.; Everson, R.; Dickinson, M.; Butler, R.; Jewitt, K. Journal: Lung cancer Issue: Volume 103(2017)Supplement 1 Page Start: S13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 86: The rate of neutropenic sepsis (NS) and other haematological toxicities in patients with advanced non-small cell lung cancer (NSCLC) treated with docetaxel in the UK NHS: REVEAL-NS. (January 2017) Authors: Talbot, T.; Dangoor, A.; Shah, R.; Naik, J.; Talbot, D.; Lester, J.F.; Cipelli, R.; Patel, A.; Summerhayes, M.; Newsom-Davis, T. Journal: Lung cancer Issue: Volume 103(2017)Supplement 1 Page Start: S40 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 87: Resource use associated with the management of docetaxel-related haematological toxicities, including neutropenic sepsis (NS), in patients with advanced non-small cell lung cancer (NSCLC) in the UK NHS: REVEAL-NS. (January 2017) Authors: Talbot, T.; Dangoor, A.; Shah, R.; Naik, J.; Lees, C.; Lester, J.F.; Cipelli, R.; Hodgson, M.; Patel, A.; Summerhayes, M.; Newsom-Davis, T. Journal: Lung cancer Issue: Volume 103(2017)Supplement 1 Page Start: S41 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗